Mid-Day Market Update: Crude Oil Up Over 3%; Cellectis Shares Plummet

Midway through trading Tuesday, the Dow traded down 0.73 percent to 21,828.07 while the NASDAQ declined 0.56 percent to 6,399.36. The S&P also fell, dropping 0.47 percent to 2,464.84.

Leading and Lagging Sectors

On Tuesday, the energy shares climbed by 0.55 percent. Meanwhile, top gainers in the sector included PHI Inc. (NASDAQ: PHII ), up 8 percent, and Patterson-UTI Energy, Inc. (NASDAQ: PTEN ), up 7 percent.

In trading on Tuesday, financial shares fell 0.98 percent. Meanwhile, top losers in the sector included Federated National Holding Co (NASDAQ: FNHC ), down 10 percent, and United Insurance Holdings Corp (NASDAQ: UIHC ) down 10 percent.

Top Headline

United Technologies Corporation (NYSE: UTX ) will acquire Rockwell Collins, Inc. (NYSE: COL ) in a deal worth $30 billion , forging an aerospace behemoth producing virtually all types of avionics systems for commercial and defense aircraft.

The purchase price includes $23 billion and the acquisition of $7 billion in Rockwell Collins debt, the two companies said in a statement.

Word of the imminent merger had been circulating in recent days. UTC was down 2.18 percent at $117.92 in premarket trading and Rockwell Collins was up 1.37 percent at $130.61. UTC is paying $140.00 per share, in cash and UTC stock.

Equities Trading UP

Insmed Incorporated (NASDAQ: INSM ) shares shot up 114 percent to $26.35 after the company disclosed that its Phase 3 CONVERT study met its primary endpoint.

Shares of Cellect Biotechnology Ltd. (NASDAQ: APOP ) got a boost, shooting up 10 percent to $10.00 after the company disclosed that its ApoGraft for acute and chronic GvHD has been granted orphan drug status by the FDA.

Energous Corp (NASDAQ: WATT ) shares were also up, gaining 12 percent to $11.33. Energous reported a new, high-power, Near Field WattUp charging solution for electronic devices.

Equities Trading DOWN

Cellectis SA (ADR) (NASDAQ: CLLS ) shares dropped 21 percent to $25.39 after announcing FDA clinical hold of UCART123 studies.

Shares of Opiant Pharmaceuticals Inc (NASDAQ: OPNT ) were down 8 percent to $35.99. Opiant Pharma named David O'Toole as CFO.

Calumet Specialty Products Partners, L.P (NYSE: CLMT ) was down, falling around 10 percent to $7.55. Janney Capital downgraded Calumet Specialty from Buy to Neutral.


In commodity news, oil traded up 3.15 percent to $48.78 while gold traded up 0.87 percent to $1,342.00.

Silver traded up 1.26 percent Tuesday to $18.04, while copper rose 1.07 percent to $3.1515.


European shares were mostly lower today. The eurozone's STOXX 600 fell 0.17 percent, the Spanish Ibex Index declined 0.57 percent, while Italy's FTSE MIB Index slipped 0.22 percent. Meanwhile the German DAX climbed 0.11 percent, and the French CAC 40 fell 0.32 percent while U.K. shares fell 0.55 percent.


U.S. factory orders dropped 3.3 percent in July, versus economists' expectations for a 3.4 percent fall.

Minneapolis Federal Reserve Bank President Neel Kashkari will speak in Minneapolis at 1:10 p.m. ET.

Dallas Federal Reserve Bank President Robert Kaplan is set to speak in Dallas at 7:00 p.m. ET.

© 2017 Benzinga does not provide investment advice. All rights reserved.

Profit with More New & Research . Gain access to a streaming platform with all the information you need to invest better today. Click here to start your 14 Day Trial of Benzinga Professional

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.